Outcome analysis of childhood pilocytic astrocytomas: a retrospective study of 148 cases at a single institution, Neuropathology and Applied Neurobiology, vol.22, issue.6, pp.693-705, 2013. ,
DOI : 10.1111/nan.12013
Objective response of multiply recurrent low-grade gliomas to bevacizumab and irinotecan, Pediatric Blood & Cancer, vol.32, issue.7, pp.791-795, 2009. ,
DOI : 10.1002/pbc.21935
Long-term efficacy and toxicity of bevacizumab-based therapy in children with recurrent low-grade gliomas, Pediatric Blood & Cancer, vol.54, issue.5, pp.776-782, 2013. ,
DOI : 10.1002/pbc.24297
Bevacizumab and irinotecan in children with recurrent or refractory brain tumors: Toxicity and efficacy trends, Pediatric Blood & Cancer, vol.44, issue.1, pp.34-38, 2012. ,
DOI : 10.1002/pbc.24066
Efficacy of bevacizumab plus irinotecan in children with recurrent low-grade gliomas--a Pediatric Brain Tumor Consortium study, Neuro-Oncology, vol.16, issue.2, pp.310-317, 2014. ,
DOI : 10.1093/neuonc/not154
Brain Tumors in Children, Archives of Neurology, vol.56, issue.4, pp.421-425, 1999. ,
DOI : 10.1001/archneur.56.4.421
Weekly vinblastine in pediatric low-grade glioma patients with carboplatin allergic reaction, Cancer, vol.105, issue.12, pp.2636-2642, 2005. ,
DOI : 10.1002/cncr.21091
Phase II Study of Weekly Vinblastine in Recurrent or Refractory Pediatric Low-Grade Glioma, Journal of Clinical Oncology, vol.30, issue.12, pp.1358-1363, 2012. ,
DOI : 10.1200/JCO.2011.34.5843
Single agent vinorelbine in pediatric patients with progressive optic pathway glioma, Journal of Neuro-Oncology, vol.46, issue.12, pp.105-112, 2015. ,
DOI : 10.1007/s11060-014-1652-6
Pilot study of a pediatric metronomic 4-drug regimen, Oncotarget, vol.2, issue.12, pp.960-965, 2011. ,
DOI : 10.18632/oncotarget.358
Metronomics: towards personalized chemotherapy?, Nature Reviews Clinical Oncology, vol.41, issue.7, pp.413-431, 2014. ,
DOI : 10.1016/j.ejca.2012.11.029
A phase II trial of a multi-agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer, Pediatric Blood & Cancer, vol.82, issue.4, pp.636-642, 2014. ,
DOI : 10.1002/pbc.24794
Metronomic Chemotherapy with the COMBAT Regimen in Advanced Pediatric Malignancies: A Multicenter Experience, Oncology, vol.82, issue.5, pp.249-260, 2012. ,
DOI : 10.1159/000336483
Maintenance chemotherapy in children with aLL exerts metronomic-like thrombospondin-1 associated anti-endothelial effect, Oncotarget, vol.6, issue.26, pp.23008-23014, 2015. ,
DOI : 10.18632/oncotarget.3984